Depression and pain: use of antidepressants
H Bonilla-Jaime, JA Sánchez-Salcedo… - Current …, 2022 - benthamdirect.com
Background: Emotional disorders are common comorbid affectations that exacerbate the
severity and persistence of chronic pain. Specifically, depressive symptoms can lead to an …
severity and persistence of chronic pain. Specifically, depressive symptoms can lead to an …
How to study anxiety and depression in rodent models of chronic pain?
Mood disorders such as depression and anxiety are frequently observed in patients
suffering from chronic pain. Over time, different tests and models have been developed in …
suffering from chronic pain. Over time, different tests and models have been developed in …
Fecal microbiota transplantation from chronic unpredictable mild stress mice donors affects anxiety-like and depression-like behavior in recipient mice via the gut …
N Li, Q Wang, Y Wang, A Sun, Y Lin, Y Jin, X Li - Stress, 2019 - Taylor & Francis
Recent studies have demonstrated that there are significant changes in the gut microbiota
(GM) of humans with depression and animal models of depression and chronic stress. In our …
(GM) of humans with depression and animal models of depression and chronic stress. In our …
Genome-wide association study of multisite chronic pain in UK Biobank
KJA Johnston, MJ Adams, BI Nicholl, J Ward… - PLoS …, 2019 - journals.plos.org
Chronic pain is highly prevalent worldwide and represents a significant socioeconomic and
public health burden. Several aspects of chronic pain, for example back pain and a severity …
public health burden. Several aspects of chronic pain, for example back pain and a severity …
Modulation of pain, nociception, and analgesia by the brain reward center
V Mitsi, V Zachariou - Neuroscience, 2016 - Elsevier
The midbrain dopamine center comprises a key network for reward, salience, motivation,
and mood. Evidence from various clinical and preclinical settings points to the midbrain …
and mood. Evidence from various clinical and preclinical settings points to the midbrain …
N‐Acetylcysteine for the treatment of psychiatric disorders: A review of current evidence
SL Ooi, R Green, SC Pak - BioMed Research International, 2018 - Wiley Online Library
N‐acetylcysteine, a sulphur‐containing amino acid for the treatment of paracetamol
overdose and chronic obstructive pulmonary disease, is a widely available off‐the‐shelf oral …
overdose and chronic obstructive pulmonary disease, is a widely available off‐the‐shelf oral …
Neuroinflammation, pain and depression: an overview of the main findings
ACP Campos, GF Antunes, M Matsumoto… - Frontiers in …, 2020 - frontiersin.org
Chronic pain is a serious public health problem with a strong affective-motivational
component that makes it difficult to treat. Most patients with chronic pain suffer from severe …
component that makes it difficult to treat. Most patients with chronic pain suffer from severe …
Glucagon-like peptide 1 (GLP-1) receptor agonists as a protective factor for incident depression in patients with diabetes mellitus: A systematic review
DH Cooper, R Ramachandra, F Ceban… - Journal of Psychiatric …, 2023 - Elsevier
Abstract Glucagon-like peptide 1 (GLP-1) receptor agonists are widely used for glycemic
control in patients with diabetes mellitus (DM) and are primarily indicated for type 2 diabetes …
control in patients with diabetes mellitus (DM) and are primarily indicated for type 2 diabetes …
Brain microglial activation in chronic pain-associated affective disorder
EE Barcelon, WH Cho, SB Jun, SJ Lee - Frontiers in neuroscience, 2019 - frontiersin.org
A growing body of evidence from both clinical and animal studies indicates that chronic
neuropathic pain is associated with comorbid affective disorders. Spinal cord microglial …
neuropathic pain is associated with comorbid affective disorders. Spinal cord microglial …
How environmental enrichment balances out neuroinflammation in chronic pain and comorbid depression and anxiety disorders
Depression and anxiety commonly occur in chronic pain states and the coexistence of these
diseases worsens outcomes for both disorders and may reduce treatment adherence and …
diseases worsens outcomes for both disorders and may reduce treatment adherence and …